Ribomax Chews By HoltraCeuticals Overview & Drug Interactions

Check For Interactions With Ribomax Chews

Supplement: Ribomax Chews by HoltraCeuticals

Ribomax Chews Label Images

This product contains

Below is a list of the 'active' ingredients listed on the supplement label for this product.

For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.

Drugs that interact with Ribomax Chews by HoltraCeuticals

Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.

Label Information

Supplement Facts:

Daily Value (DV) Target Group(s): Adults and children 4 or more years of age
Minimum serving Sizes:
1 Tablet(s)
Maximum serving Sizes:
1 Tablet(s)
Servings per container 90

Ingredient Amount per Serving Group % DV, Adults & children 4+ years
Calories
10 {Calories}
Header
Total Carbohydrates
2 g
Carbohydrate 2%
Sugar
1.67 g
Sucrose
Sugar Alcohol
0.5 g
Sugar Alcohol --
D-Ribose
1.67 g
Ribose --

Other Ingredients:
Xylitol
Cellulose
Hydroxypropylcellulose
natural orange and vanilla flavors
Citric Acid
Mannitol
Vegetable Stearate
Stearic Acid
natural Palm Wax
Silica


Label Statments:


Formulation
- This product contains NO salt, yeast, wheat, gluten, soy, corn, dairy products, artificial flavoring or colors, preservatives or ingredients of animal origin.
Precautions
- Caution: Insulin-dependent diabetics and pregnant women should consult their healthcare professional before use.
- Tamper resistant package, do not use if outer seal is missing.
- KEEP OUT OF REACH OF CHILDREN.
Storage
- For optimal storage conditions, store in a cool, dry place. (59(0)-77(0)F/15(0)-25(0)C) (35-65% relative humidity)
General Statements
- Formula #201245 / 2260009
- *Supports cardiac health and skeletal muscle function
FDA Statement of Identity
- Dietary Supplement
Brand IP Statement(s)
- HOLTORF MEDICAL GROUP(R) CENTERS FOR HORMONE IMBALANCE, HYPOTHYROIDISM AND FATIGUE
- Protected by U.S. patents 6,159,942; 6,534,480; 6,218,366; 6,339,716; 6,703,370 and other U.S. and foreign patents issued and pending
- (C)2008 Bioenergy, Inc.
Suggested/Recommended/Usage/Directions
- Suggested Usage: Take one chewable tablet one to three times daily with food or as directed by your healthcare professional.
FDA Disclaimer Statement
- This statement has not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease.

Brand Information

See all products by this brand

To Reorder visit
Web Address HoltraCeuticals.com
Manufactured for
Name Kent Holtorf, MD and the Holtorf Medical Group(R)
City Torrance
State CA
Phone Number (310) 375-2705

Return to the main supplement interaction checker page

Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Drug descriptions are provided by MedlinePlus.